MONTECALVO DAVID A 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Jul 30, 2020
Insider Transaction Report
Form 4
MONTECALVO DAVID A
SVP, Glob Ops and Supply Chain
Transactions
- Sale
Common Stock
2020-07-28$264.13/sh−7,773$2,053,094→ 10,243.42 total - Exercise/Conversion
Common Stock
2020-07-29$83.47/sh+5,358$447,232→ 9,582.42 total - Exercise/Conversion
Common Stock
2020-07-28$83.47/sh+3,000$250,410→ 18,732.42 total - Sale
Common Stock
2020-07-28$265.98/sh−3,000$797,931→ 4,224.42 total - Sale
Common Stock
2020-07-28$265.13/sh−2,881$763,837→ 7,362.42 total - Exercise/Conversion
Stock Options (Right to buy)
2020-07-29−5,358→ 2,786 totalExercise: $83.47From: 2018-02-21Exp: 2027-02-21→ Common Stock (5,358 underlying) - Exercise/Conversion
Common Stock
2020-07-28$71.79/sh+10,792$774,758→ 15,732.42 total - Sale
Common Stock
2020-07-28$266.06/sh−716$190,498→ 18,016.42 total - Sale
Common Stock
2020-07-28$265.85/sh−138$36,687→ 7,224.42 total - Sale
Common Stock
2020-07-29$270.70/sh−3,273$886,014→ 6,309.42 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-07-28−10,792→ 0 totalExercise: $71.79From: 2017-02-23Exp: 2026-09-26→ Common Stock (10,792 underlying) - Exercise/Conversion
Stock Options (Right to buy)
2020-07-28−3,000→ 8,144 totalExercise: $83.47From: 2018-02-21Exp: 2027-02-21→ Common Stock (3,000 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $263.80 to $264.79, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F2]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $264.80 to $265.77, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F3]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $265.80 to $265.87, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F4]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $265.9762 to $265.9769, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.